CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...

Entrance to a CVS Pharmacy in Manhattan. (Photo by ... More Erik McGregor/LightRocket via ) LightRocket via Getty Imag ...

CVS Health shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results easily topped ...

2024 when TD Cowen changed their price target from $99 to $59 for CVS Health Corp. Analysts arrive at stock ratings after doing extensive research, which includes going through public financial ...

Discover why CVS' turnaround may be underway with improved medical cost trends, segment growth, and raised FY2025 guidance.

She most recently served as chief physician executive of healthcare performance improvement ... After today's rebound, CVS Health stock is up more than 50% year to date. Is the stock a buy?

Shares of CVS Health Corp. CVS soared toward a one-year high in early Thursday trading, after the healthcare-services company dropped a bombshell on investors — it’s leaving the Obamacare ...

CVS reported $97.7 billion in revenue and adjusted EPS of $1.19, above the estimates, driven by strong performance ... expects limited stock buying in the managed care and healthcare facilities ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

CVS Health sees strong Q1 2025 growth, but risks loom with downgraded revenue guidance and Medicare challenges. Read my analysis on CVS stock's earnings here.